Azulene Labs raises $3.4M to make chemistry simulation predictive
What's the deal? Azulene LabsDealroom has a profile for this one. Try Dealroom → has raised $3.4 million in a pre-seed round to build physics-based AI models for drug discovery, materials development, and industrial chemistry. Ground State VenturesDealroom has a profile for this one. Try Dealroom → led the round, with participation from existing investor Entrada VenturesDealroom has a profile for this one. Try Dealroom → and angels.
What's the endgame? The startup is rebuilding the chemistry simulation stack to make molecular modeling predictive — closer to how aerospace and civil engineering already work. Its foundation models use quantum-mechanical training data, which the company says delivers around 100 times the efficiency and at least 200 times the cost-effectiveness of competitors.
Why does it matter? Chemistry modeling remains imprecise. Azulene says that even after sixty years of computer modeling, predictions of how tightly a drug binds to its target protein are still routinely wrong by a factor of 100 or more.
Why now? Recent AI advances in chemistry modeling still produce structures that are deeply inaccurate or physically impossible, according to Azulene. It says its models are constrained to the laws of physics in ways current models are not.
"Chemistry should work the way aerospace engineering already works, where you design the thing in a computer, you believe the answer, and the physical object behaves as predicted the first time you build it," says co-founder Nicolas Sawaya.
Who's behind it? Sawaya holds a PhD in chemical physics from Harvard and previously led quantum algorithm development for chemistry at Intel LabsDealroom has a profile for this one. Try Dealroom →. The founding team includes scientists with PhDs from Caltech, Harvard, UC Berkeley, Columbia, and MIPT.
What's the money for? Azulene plans to expand its team and product development. It is currently working with end-users in the biotech and industrial chemistry markets, with potential applications across pharma, agriculture, energy storage, plastics, and industrial chemicals.
The signal: The round sits in the 34th percentile by amount, a modest entry point for a deep-tech bet with a long research horizon. Investors are wagering that physics-constrained models can outperform data-hungry AI in a field where accuracy has long been the bottleneck. As Ground State's Ton van 't Noordende puts it, the aim is for Azulene to become "the Anthropic of chemistry."
Image credit: ChiralJon
